ELRIG Advances in Cell-based Screening in Drug Discovery 2026
The ELRIG Advances in Cell-based Screening in Drug Discovery 2026 event, held May 6-7 at AstraZeneca in Gothenburg, Sweden, focuses on transforming early drug discovery by shifting from animal-based to human cell-based models and integrating AI to improve predictive accuracy, with collaborative discussions aimed at redefining hit-to-lead processes for delivering transformative therapies.
ELRIG Advances in Cell-based Screening in Drug Discovery 2026
Date: May 6-7
Location: AstraZeneca, Gothenburg, Sweden
This event is essential for professionals across the cell-based discovery continuum who are actively preparing for an AI-driven future.
Through collaborative dialogue, the aim is to help the community rework early discovery from animal-gated milestones to human-first decision making. This new blueprint requires deliberation on how hit-to-lead processes should change, where cells should replace animals, and how AI can enhance the predictive accuracy of efforts to deliver transformative therapies.
Join the Dotmatics team at Booth #29 to be part of this conversation.
Event Details:
- Dates: May 6-7
- Time: 8:00 a.m. - 5:00 p.m.
- Location: AstraZeneca, Gothenburg, Sweden